ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

Grantees May Get More Freedom In Adjusting budgets

February 21, 1975

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

Cooperative Group Chairmen Told They Must Do Their Own Planning, Will Get Funds Increase

September 26, 1975

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000

Existing HER2 Drugs May Help More In Breast Cancer Treatment

January 25, 2013

NCCR Seeks #380 Mil. Increase For NIC In FY 1994; Calls ‘First Step’ In Reaching Byspass Budget Level

February 26, 1993